Standard Life Aberdeen Stock London S.E.
Equities
GB00BVFD7Q58
Investment Management & Fund Operators
Sales 2024 * | 1.32B 1.68B | Sales 2025 * | 1.31B 1.67B | Capitalization | 2.76B 3.52B |
---|---|---|---|---|---|
Net income 2024 * | 98M 125M | Net income 2025 * | 134M 171M | EV / Sales 2024 * | 1.57 x |
Net cash position 2024 * | 688M 877M | Net cash position 2025 * | 645M 822M | EV / Sales 2025 * | 1.61 x |
P/E ratio 2024 * |
27
x | P/E ratio 2025 * |
20.5
x | Employees | - |
Yield 2024 * |
9.43% | Yield 2025 * |
9.43% | Free-Float | 97.59% |
Latest transcript on Standard Life Aberdeen
Managers | Title | Age | Since |
---|---|---|---|
Jason Windsor
CEO | Chief Executive Officer | 51 | 23-10-30 |
David Scott
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-31 |
Mark Dixon
CTO | Chief Tech/Sci/R&D Officer | 62 | 10-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Flint
CHM | Chairman | 67 | 18-10-31 |
Director/Board Member | 68 | 18-07-31 | |
John Devine
BRD | Director/Board Member | 66 | 16-07-03 |
1st Jan change | Capi. | |
---|---|---|
-4.98% | 115B | |
+6.97% | 99.65B | |
+11.82% | 67.53B | |
+23.96% | 65.78B | |
+11.89% | 43.55B | |
+14.52% | 43.2B | |
+19.74% | 36.01B | |
+8.02% | 25.98B | |
-4.58% | 22.27B |